Tag: gastrointestinal

  • Gastrointestinal Bleeding Treatment Devices Market Forecast Reveals Where Future Industry Value Will Be Created

    Gastrointestinal Bleeding Treatment Devices Market Forecast Reveals Where Future Industry Value Will Be Created

    Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

    The market for gastrointestinal bleeding treatment devices is experiencing steady growth, fueled by advances in technology and increasing demand for effective treatment options. As the prevalence of gastrointestinal disorders rises worldwide, this sector is positioned for expansion, with innovations and clinical needs driving further development. Let’s explore the market size, growth factors, key segments, and competitive landscape shaping this industry.

    Gastrointestinal Bleeding Treatment Devices Market Size and Growth Forecast

    The gastrointestinal bleeding treatment devices market has witnessed notable expansion recently. It is projected to increase from $0.92 billion in 2025 to $1 billion in 2026, marking a compound annual growth rate (CAGR) of 8.7%. Historical growth has been driven by rising instances of gastrointestinal disorders, increased prevalence of peptic ulcer disease, the expanding use of endoscopic diagnostic procedures, more hospital-based gastrointestinal interventions, and greater availability of advanced endoscopy equipment. Looking ahead, the market is expected to reach $1.39 billion by 2030, growing at a CAGR of 8.6%. This forecast is supported by the adoption of next-generation endoscopic devices, growing demand for outpatient gastrointestinal procedures, heightened focus on early bleeding detection, the rise of ambulatory surgical centers, and increased investments in advanced gastrointestinal care technologies. Key trends expected to influence growth include greater use of advanced endoscopic hemostasis devices, minimally invasive treatment methods, precision thermal ablation tools, expanding mechanical hemostatic solutions, and a strong emphasis on rapid bleeding control.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    Factors Contributing to the Rising Demand in the Gastrointestinal Bleeding Treatment Devices Market

    One of the main reasons behind the market’s lucrative prospects is the growing burden of gastrointestinal disorders globally. Conditions affecting the digestive system are often linked to factors such as low fiber intake, high stress, insufficient water consumption, excessive dairy intake, sedentary lifestyles, aging, and genetic predispositions. For example, a report released in October 2024 by the US National Library of Medicine highlighted that in 2023, 825 per 100,000 Canadians were diagnosed with inflammatory bowel disease (IBD), affecting over 320,000 people. Projections suggest this number could rise to around 470,000 individuals, or 1.1% of the population, by 2035. This increase in gastrointestinal disease prevalence is a key driver for growth in the gastrointestinal bleeding treatment devices sector.

    Detailed Segment Breakdown of the Gastrointestinal Bleeding Treatment Devices Market

    This market is categorized into several segments based on product type, gastrointestinal tract division, and end user. By product, the market includes Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents and Powders, and Combination or Multimodal Hemostasis Devices. Regarding the GI tract division, the market is split into Upper GI Tract and Lower GI Tract. End users primarily consist of Hospitals or Clinics, Ambulatory Surgical Centers, and other relevant facilities. Further subcategories delve into specific device types, such as Electrocautery and Electrosurgical Coagulation Devices, Argon Plasma Coagulation Devices, Hemostatic Clips, Endoscopic Band Ligation Devices, Epinephrine Injection Systems, Hemostatic Powder Sprays, and integrated multimodal endoscopic platforms, among others.

    Access The Complete Gastrointestinal Bleeding Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Innovations and Strategic Developments Defining Market Growth

    Leading companies in this sector are focusing on creating advanced solutions to improve treatment outcomes. One prominent example is Hemospray, a hemostatic powder designed to control active gastrointestinal bleeding during endoscopic procedures. Notably, in January 2024, AIG Hospitals in India introduced Hemospray as a breakthrough technology for managing GI bleeding. Its ease of use, safety, and effectiveness in controlling a wide range of GI bleeds—from peptic ulcers to variceal hemorrhages—make it a significant advancement in the field.

    Key Players and Competitive Landscape in the Gastrointestinal Bleeding Treatment Devices Market

    The industry features several major players driving innovation and market penetration. These include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., and Hemostasis LLC.

    Regional Market Insights Highlighting Areas of Opportunity

    In 2025, North America held the largest share of the gastrointestinal bleeding treatment devices market. However, the Asia-Pacific region is anticipated to exhibit the fastest growth rate during the forecast period. The market coverage extends across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics and future prospects.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gastrointestinal Bleeding Treatment Devices Market Forecast Covering Industry Demand And Market Evolution

    Gastrointestinal Bleeding Treatment Devices Market Forecast Covering Industry Demand And Market Evolution

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    What Market Value Expansion Is Expected For The Gastrointestinal Bleeding Treatment Devices Market Over The Forecast Period?

    The gastrointestinal bleeding treatment devices market size has shown strong growth recently. It is anticipated to expand from $0.92 billion in 2025 to $1 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. This historic expansion can be linked to an increasing occurrence of gastrointestinal disorders, a rise in the prevalence of peptic ulcer disease, the broadening of endoscopic diagnostic procedures, a growth in hospital-based GI interventions, and the wider availability of advanced endoscopy equipment.

    The gastrointestinal bleeding treatment devices market size is projected to experience substantial expansion in the coming years, expected to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This anticipated growth during the forecast period is driven by the increasing integration of next-generation endoscopic devices, a rising demand for outpatient GI procedures, a greater focus on early bleeding detection, the expansion of ambulatory surgical centers, and increasing investments in advanced GI care technologies. Prominent trends observed in the forecast period include the growing adoption of advanced endoscopic hemostasis devices, an increase in the use of minimally invasive GI bleeding treatments, escalating demand for precision thermal ablation tools, the expansion of mechanical hemostatic solutions, and an enhanced focus on rapid bleeding control technologies.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    What Primary Factors Are Fueling The Expansion Of The Gastrointestinal Bleeding Treatment Devices Market?

    The escalating prevalence of gastrointestinal disorders is predicted to significantly enhance market profitability. These conditions are often triggered by factors such as a low fiber diet, chronic stress, insufficient water intake, high consumption of dairy foods, an inactive lifestyle, aging, and genetic predispositions. For example, in October 2024, the National Library of Medicine, a US-based national library, reported, based on 2023 data, that 825 per 100,000 Canadians suffer from inflammatory bowel disease (IBD), affecting over 320,000 individuals. Projections indicate that this figure could reach 1.1% of the population, or around 470,000 Canadians, by 2035. Therefore, the increasing incidence of GI tract-related disorders is a key market driver.

    How Does Segment Analysis Break Down The Gastrointestinal Bleeding Treatment Devices Market Structure?

    The gastrointestinal bleeding treatment devices market covered in this report is segmented –

    1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices

    2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices

    3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems

    4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents

    5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms

    What Trends Are Affecting The Gastrointestinal Bleeding Treatment Devices Market Dynamics?

    Leading companies within the gastrointestinal bleeding treatment devices market are concentrating on developing advanced solutions, such as Hemospray, to enhance the effectiveness of treating acute bleeding in the GI tract. Hemospray functions as a hemostatic powder engineered to manage and control active GI bleeding. For instance, AIG Hospitals, based in India, launched Hemospray in January 2024, marking a significant advancement in controlling GI bleeding. This hemostatic agent is specifically formulated for use in endoscopic procedures to address acute gastrointestinal bleeding. Hemospray is particularly recognized for its ease of use, strong safety profile, and capacity to control a wide array of GI bleeds, ranging from peptic ulcers to variceal hemorrhages.

    Who Are The Leading Firms Participating In The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    Access The Complete Gastrointestinal Bleeding Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Which Regional Market Leads The Gastrointestinal Bleeding Treatment Devices Market?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Gastrointestinal Bleeding Treatment Devices Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company

    Bleeding Disorders Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

    Gastrointestinal Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

    Bleeding Disorder Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    By 2030, What Market Size Is The Gastrointestinal Bleeding Treatment Devices Market Expected To Reach Based On Its 2026 Value?

    The gastrointestinal bleeding treatment devices market has seen significant expansion in recent years. It is anticipated to increase from $0.92 billion in 2025 to $1 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The expansion observed in prior periods can be attributed to a rising occurrence of gastrointestinal disorders, an increasing prevalence of peptic ulcer disease, the growth of endoscopic diagnostic procedures, an uptick in hospital-based GI interventions, and the availability of sophisticated endoscopy equipment.

    The gastrointestinal bleeding treatment devices market is anticipated to experience substantial growth in the upcoming years, with its valuation expected to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This expansion during the forecast period is driven by factors such as the increasing adoption of next-generation endoscopic devices, a rising demand for outpatient GI procedures, a growing focus on early bleeding detection, the continued expansion of ambulatory surgical centers, and increased investments in advanced GI care technologies. Key trends influencing this period include the increasing adoption of advanced endoscopic hemostasis devices, a rising use of minimally invasive GI bleeding treatments, a growing demand for precision thermal ablation tools, the expansion of mechanical hemostatic solutions, and an enhanced focus on rapid bleeding control technologies.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    Which Major Drivers Are Influencing The Expansion Of The Gastrointestinal Bleeding Treatment Devices Market?

    The growing prevalence of gastrointestinal disorders is anticipated to significantly boost market profitability. These conditions often stem from various factors, including an insufficient fiber diet, stress, inadequate hydration, high dairy consumption, a sedentary lifestyle, advancing age, and genetic predispositions. A notable example comes from a 2023 report by the National Library of Medicine, a US-based national library (as cited in October 2024), which stated that 825 per 100,000 Canadians are affected by inflammatory bowel disease (IBD), totaling over 320,000 individuals. Furthermore, projections suggest this figure could escalate to 1.1% of the population, equating to around 470,000 Canadians, by 2035. Consequently, the rising occurrence of conditions impacting the GI tract is a significant market driver.

    How Are Different Segments Classified In The Gastrointestinal Bleeding Treatment Devices Market Segment Analysis?

    The gastrointestinal bleeding treatment devices market covered in this report is segmented –

    1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices

    2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices

    3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems

    4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents

    5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms

    Which Trends Are Shaping The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are focusing on the development of advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the GI tract. Hemospray is a hemostatic powder designed to manage and control active bleeding within the gastrointestinal tract. For instance, in January 2024, AIG Hospitals, an India-based hospital, introduced Hemospray, representing a significant breakthrough in controlling GI bleeding. This hemostatic agent is specifically engineered for use in endoscopic procedures to manage acute gastrointestinal bleeding. Hemospray is notable for its ease of use, strong safety profile, and its capability to control a wide range of GI bleeds, from peptic ulcers to variceal hemorrhages.

    Who Are The Companies Driving Activity In The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    Get The Full Gastrointestinal Bleeding Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Which Region Holds The Highest Market Share In The Gastrointestinal Bleeding Treatment Devices Market?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Gastrointestinal Bleeding Treatment Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

    Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company

    Bleeding Disorders Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

    Gastrointestinal Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

    Bleeding Disorder Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    By 2030, What Market Size Is The Gastrointestinal Bleeding Treatment Devices Market Expected To Reach Based On Its 2026 Value?

    The gastrointestinal bleeding treatment devices market has seen significant expansion in recent years. It is anticipated to increase from $0.92 billion in 2025 to $1 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The expansion observed in prior periods can be attributed to a rising occurrence of gastrointestinal disorders, an increasing prevalence of peptic ulcer disease, the growth of endoscopic diagnostic procedures, an uptick in hospital-based GI interventions, and the availability of sophisticated endoscopy equipment.

    The gastrointestinal bleeding treatment devices market is anticipated to experience substantial growth in the upcoming years, with its valuation expected to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This expansion during the forecast period is driven by factors such as the increasing adoption of next-generation endoscopic devices, a rising demand for outpatient GI procedures, a growing focus on early bleeding detection, the continued expansion of ambulatory surgical centers, and increased investments in advanced GI care technologies. Key trends influencing this period include the increasing adoption of advanced endoscopic hemostasis devices, a rising use of minimally invasive GI bleeding treatments, a growing demand for precision thermal ablation tools, the expansion of mechanical hemostatic solutions, and an enhanced focus on rapid bleeding control technologies.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    Which Major Drivers Are Influencing The Expansion Of The Gastrointestinal Bleeding Treatment Devices Market?

    The growing prevalence of gastrointestinal disorders is anticipated to significantly boost market profitability. These conditions often stem from various factors, including an insufficient fiber diet, stress, inadequate hydration, high dairy consumption, a sedentary lifestyle, advancing age, and genetic predispositions. A notable example comes from a 2023 report by the National Library of Medicine, a US-based national library (as cited in October 2024), which stated that 825 per 100,000 Canadians are affected by inflammatory bowel disease (IBD), totaling over 320,000 individuals. Furthermore, projections suggest this figure could escalate to 1.1% of the population, equating to around 470,000 Canadians, by 2035. Consequently, the rising occurrence of conditions impacting the GI tract is a significant market driver.

    How Are Different Segments Classified In The Gastrointestinal Bleeding Treatment Devices Market Segment Analysis?

    The gastrointestinal bleeding treatment devices market covered in this report is segmented –

    1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices

    2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices

    3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems

    4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents

    5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms

    Which Trends Are Shaping The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are focusing on the development of advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the GI tract. Hemospray is a hemostatic powder designed to manage and control active bleeding within the gastrointestinal tract. For instance, in January 2024, AIG Hospitals, an India-based hospital, introduced Hemospray, representing a significant breakthrough in controlling GI bleeding. This hemostatic agent is specifically engineered for use in endoscopic procedures to manage acute gastrointestinal bleeding. Hemospray is notable for its ease of use, strong safety profile, and its capability to control a wide range of GI bleeds, from peptic ulcers to variceal hemorrhages.

    Who Are The Companies Driving Activity In The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    Get The Full Gastrointestinal Bleeding Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Which Region Holds The Highest Market Share In The Gastrointestinal Bleeding Treatment Devices Market?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Gastrointestinal Bleeding Treatment Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

    Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company

    Bleeding Disorders Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

    Gastrointestinal Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

    Bleeding Disorder Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    By 2030, What Market Size Is The Gastrointestinal Bleeding Treatment Devices Market Expected To Reach Based On Its 2026 Value?

    The gastrointestinal bleeding treatment devices market has seen significant expansion in recent years. It is anticipated to increase from $0.92 billion in 2025 to $1 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The expansion observed in prior periods can be attributed to a rising occurrence of gastrointestinal disorders, an increasing prevalence of peptic ulcer disease, the growth of endoscopic diagnostic procedures, an uptick in hospital-based GI interventions, and the availability of sophisticated endoscopy equipment.

    The gastrointestinal bleeding treatment devices market is anticipated to experience substantial growth in the upcoming years, with its valuation expected to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This expansion during the forecast period is driven by factors such as the increasing adoption of next-generation endoscopic devices, a rising demand for outpatient GI procedures, a growing focus on early bleeding detection, the continued expansion of ambulatory surgical centers, and increased investments in advanced GI care technologies. Key trends influencing this period include the increasing adoption of advanced endoscopic hemostasis devices, a rising use of minimally invasive GI bleeding treatments, a growing demand for precision thermal ablation tools, the expansion of mechanical hemostatic solutions, and an enhanced focus on rapid bleeding control technologies.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    Which Major Drivers Are Influencing The Expansion Of The Gastrointestinal Bleeding Treatment Devices Market?

    The growing prevalence of gastrointestinal disorders is anticipated to significantly boost market profitability. These conditions often stem from various factors, including an insufficient fiber diet, stress, inadequate hydration, high dairy consumption, a sedentary lifestyle, advancing age, and genetic predispositions. A notable example comes from a 2023 report by the National Library of Medicine, a US-based national library (as cited in October 2024), which stated that 825 per 100,000 Canadians are affected by inflammatory bowel disease (IBD), totaling over 320,000 individuals. Furthermore, projections suggest this figure could escalate to 1.1% of the population, equating to around 470,000 Canadians, by 2035. Consequently, the rising occurrence of conditions impacting the GI tract is a significant market driver.

    How Are Different Segments Classified In The Gastrointestinal Bleeding Treatment Devices Market Segment Analysis?

    The gastrointestinal bleeding treatment devices market covered in this report is segmented –

    1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices

    2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices

    3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems

    4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents

    5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms

    Which Trends Are Shaping The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are focusing on the development of advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the GI tract. Hemospray is a hemostatic powder designed to manage and control active bleeding within the gastrointestinal tract. For instance, in January 2024, AIG Hospitals, an India-based hospital, introduced Hemospray, representing a significant breakthrough in controlling GI bleeding. This hemostatic agent is specifically engineered for use in endoscopic procedures to manage acute gastrointestinal bleeding. Hemospray is notable for its ease of use, strong safety profile, and its capability to control a wide range of GI bleeds, from peptic ulcers to variceal hemorrhages.

    Who Are The Companies Driving Activity In The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    Get The Full Gastrointestinal Bleeding Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Which Region Holds The Highest Market Share In The Gastrointestinal Bleeding Treatment Devices Market?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Gastrointestinal Bleeding Treatment Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

    Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company

    Bleeding Disorders Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

    Gastrointestinal Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

    Bleeding Disorder Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gastrointestinal Bleeding Treatment Devices Market 2026–2030: Emerging Trends and Forecast Opportunities

    Gastrointestinal Bleeding Treatment Devices Market 2026–2030: Emerging Trends and Forecast Opportunities

    Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

    Across 2026–2030, what is the expected market valuation path of the Gastrointestinal Bleeding Treatment Devices Market?

    The market size for gastrointestinal bleeding treatment devices has experienced robust expansion in recent years. This market is projected to expand from $0.92 billion in 2025 to $1 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.7%. Historically, this growth has been driven by factors such as the increasing occurrence of gastrointestinal disorders, the rising prevalence of peptic ulcer disease, the proliferation of endoscopic diagnostic procedures, the surge in hospital-based GI interventions, and the accessibility of sophisticated endoscopy equipment.

    The market for gastrointestinal bleeding treatment devices is projected to experience substantial expansion in the coming years, anticipated to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This growth during the forecast period is fueled by several factors, including the increasing integration of next-generation endoscopic devices, the rising need for outpatient GI procedures, an intensifying focus on detecting bleeding early, the expansion of ambulatory surgical centers, and growing investments in sophisticated GI care technologies. Key trends defining this period encompass the wider adoption of advanced endoscopic hemostasis devices, an increase in the utilization of minimally invasive GI bleeding treatments, a surging demand for precision thermal ablation tools, the proliferation of mechanical hemostatic solutions, and a heightened emphasis on technologies for rapid bleeding control.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    Which Drivers Are Supporting The Rise Of The Gastrointestinal Bleeding Treatment Devices Market?

    The growing occurrence of gastrointestinal disorders is projected to enhance the market’s profitability. Factors such as an insufficient fiber intake, stress, inadequate hydration, excessive consumption of dairy products, a sedentary lifestyle, advancing age, and genetic predispositions can lead to gastrointestinal diseases. As an illustration, in October 2024, data from the National Library of Medicine, a US-based national library, indicated that in 2023, 825 per 100,000 Canadians were afflicted with inflammatory bowel disease (IBD), impacting over 320,000 individuals. Furthermore, forecasts suggest this figure might escalate to 1.1% of the population, which translates to approximately 470,000 Canadians, by 2035. Consequently, the rising incidence of disorders associated with the GI tract is propelling market expansion.

    What Segments Are Identified Within The Structure Of The Gastrointestinal Bleeding Treatment Devices Market?

    The gastrointestinal bleeding treatment devices market covered in this report is segmented –

    1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices

    2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices

    3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems

    4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents

    5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms

    Which Market Trends Are Opening Growth Opportunities In The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are concentrating on developing advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the gastrointestinal (GI) tract. Hemospray functions as a hemostatic powder specifically designed to manage and control active bleeding within the GI tract. For instance, in January 2024, AIG Hospitals, an India-based hospital, introduced Hemospray, which represents a significant breakthrough in controlling GI bleeding. This hemostatic agent is specifically formulated for use in endoscopic procedures to control acute gastrointestinal (GI) bleeding. Hemospray is recognized for its ease of use, strong safety profile, and its capability to manage a wide range of GI bleeds, from conditions like peptic ulcers to variceal hemorrhages.

    Which Leading Companies Dominate The Gastrointestinal Bleeding Treatment Devices Market Share?

    Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    How Does The Gastrointestinal Bleeding Treatment Devices Market Perform Across Major Global Regions?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Gastrointestinal Bleeding Treatment Devices Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

    Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company

    Bleeding Disorders Treatment Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

    Gastrointestinal Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

    Bleeding Disorder Testing Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company